Sen and Chatterjee (2011) [58] showed that EGCG downregulates EGF-induced matrix metalloproteinase-9 (MMP9) in ER+ breast cancer cells, thereby shutting down cell invasion and metastasis [58]. Here, MMP9 is linked to breast carcinoma.